hydrate saxagliptin hydrate (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)2-azabicyclo(3.1.0)hexane-3-carbonitrile monohydrate (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile--water (1/1) 333.205 333.42530 A hydrate that is the monohydrate form of anhydrous saxagliptin. Used for the treatment of Type II diabetes. AFNTWHMDBNQQPX-NHKADLRUSA-N C18H27N3O3 CAS:945667-22-1 CHEBI:71271 DrugBank:DB06335 InChI=1S/C18H25N3O2.H2O/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;/h10-15,23H,1-7,9,20H2;1H2/t10?,11?,12-,13+,14+,15-,17?,18?;/m1./s1 KEGG:D09753 O.[H][C@]12C[C@@H](C#N)N(C(=O)[C@@H](N)C34CC5CC(CC(O)(C5)C3)C4)[C@@]1([H])C2 Onglyza PMID:19890244 PMID:20402634 PMID:20460554 PMID:21042540 PMID:21086586 PMID:21348538 PMID:21437102 PMID:22001114 PMID:22054301 PMID:22221000 PMID:22349123 PMID:22776778 PMID:22943617 Patent:WO2008131149 Reaxys:18655324 chebi_ontology saxagliptin monohydrate